Table 3

Patients with any kind of diabetic retinopathy and associated risk factors

Any DR
N (%)
Mild-NPDR
N (%)
Moderate-NPDR
N (%)
Severe-NPDR
N (%)
PDR
N (%)
DMO
N (%)
*P value
Sex0.001
 Male7469 (12.2)4464 (7.29)2092 (3.42)581 (0.95)216 (0.35)116 (0.19)
 Female5918 (12.4)3680 (7.71)1608 (3.36)363 (0.76)184 (0.38)83 (0.17)
 Total13 387 (12.3)8144 (7.48)3700 (3.39)944 (0.86)400 (0.36)199 (0.18)
Diabetes time duration (years)<0.001
 <52420 (6.9)1580 (4.50)607 (1.73)146 (0.42)47 (0.14)40 (0.11)
 5–95907 (12.5)3633 (7.68)1623 (3.44)396 (0.84)170 (0.36)85 (0.18)
 10–153083 (17.2)1847 (10.31)851 (4.74)221 (1.23)121 (0.68)43 (0.24)
 >151977 (23.7)1084 (12.99)619 (7.43)181 (2.17)62 (0.74)31 (0.37)
A1C (%)<0.001
 ≤7.04360 (8.4)2912 (5.61)1042 (2.01)236 (0.45)99 (0.19)71 (0.14)
 >7.0 to <7.93193 (13.3)1933 (8.05)918 (3.82)215 (0.90)92 (0.38)35 (0.15)
 8 to 91868 (18.4)1064 (10.47)560 (5.52)150 (1.48)67 (0.66)27 (0.27)
 >92026 (22.9)1084 (12.25)650 (7.35)191 (2.16)71 (0.80)30 (0.34)
Insulin treatment<0.001
 No8273 (9.2)5370 (5.97)2146 (2.39)453 (0.50)182 (0.20)122 (0.14)
 Yes5114 (27.7)2774 (15.03)1554 (8.42)491 (2.65)218 (1.18)77 (0.42)
Smoking Status0.182
 Smoker1573 (10.7)968 (6.58)441 (3.00)104 (0.71)45 (0.31)15 (0.10)
 Past-smoker3486 (11.9)2085 (7.13)991 (3.38)264 (0.90)89 (0.30)54 (0.18)
 Never-smoker8274 (12.9)5060 (7.89)2252 (3.51)568 (0.89)264 (0.41)130 (0.20)
Hypertension<0.001
 No1976 (9.1)1275 (5.87)516 (2.38)128 (0.58)36 (0.17)21 (0.10)
 Yes11 411 (13.1)6869 (7.89)3184 (3.66)816 (0.93)364 (0.42)178 (0.20)
Blood pressure (mm Hg)<0.001
 ≥140/904487 (15.4)2620 (8.99)1316 (4.52)338 (1.16)143 (0.49)70 (0.24)
 <140/907490 (10.9)4664 (6.79)2007 (2.92)484 (0.70)224 (0.33)111 (0.16)
No HDL-cholesterol (mmol/L)0.272
 ≥3.32353 (10.5)1437 (6.41)632 (2.82)183 (0.82)65 (0.29)36 (0.16)
 <3.38390 (12.6)5105 (7.67)2366 (3.55)559 (0.84)247 (0.37)113 (0.17)
  • *p Value for group comparison with Pearson's χ2 test for qualitative variables and ANOVA for the quantitative ones.

  • A1C, glycated haemoglobin; DMO, diabetic macular oedema; DR, diabetic retinopathy; NPDR, non-proliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy.